To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?

Simple item page
dc.contributor.authorMarciano, N.
dc.contributor.authorMerlin, T.
dc.contributor.authorBessen, T.
dc.contributor.authorStreet, J.
dc.date.issued2014
dc.description.abstractBackground: Clinical practice guidelines should aim to assist clinicians in making evidence-based choices in the care of their patients. This review attempts to determine the extent of evidence-based support for clinical practice guideline recommendations concerning cutaneous melanoma follow up and to evaluate the methodological quality of these guidelines. Methods: Current guidelines providing graded recommendations regarding patient follow up were identified through a systematic literature review. The authors reviewed the evidence base used to formulate recommendations in each of the guidelines and appraised the quality of the guidelines using the AGREE II (Appraisal of Guidelines for Research and Evaluation) instrument. Results: Most guideline recommendations concerning the frequency of routine skin examinations by a clinician and the use of imaging and diagnostic tests in the follow up of melanoma patients were based on low-level evidence or consensus expert opinion. Melanoma follow-up guidelines are of variable methodological quality, with some guidelines not recommended by the appraisers for use in clinical practice. Conclusion: Clinicians should be aware of how scant the evidence base is for many recommended courses of action. As a consequence of the paucity of evidence in the field of melanoma follow up, there is considerable variability in the guidance provided. The variable methodological quality of guidelines for melanoma follow up could be improved by attention to the criteria described in AGREE II.
dc.description.statementofresponsibilityN. J. Marciano, T. L. Merlin, T. Bessen, J. M. Street
dc.identifier.citationInternational Journal of Clinical Practice, 2014; 68(6):761-770
dc.identifier.doi10.1111/ijcp.12393
dc.identifier.issn1368-5031
dc.identifier.issn1742-1241
dc.identifier.orcidMerlin, T. [0000-0002-7293-4262]
dc.identifier.orcidBessen, T. [0000-0003-2944-3545]
dc.identifier.orcidStreet, J. [0000-0002-1033-4341]
dc.identifier.urihttp://hdl.handle.net/2440/94747
dc.language.isoen
dc.publisherWiley
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/565501
dc.rights© 2014 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
dc.source.urihttps://doi.org/10.1111/ijcp.12393
dc.subjectHumans
dc.subjectMelanoma
dc.subjectSkin Neoplasms
dc.subjectFollow-Up Studies
dc.subjectConsensus
dc.subjectEvidence-Based Medicine
dc.subjectGuidelines as Topic
dc.subjectMelanoma, Cutaneous Malignant
dc.titleTo what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_94747.pdf
Size:
310.82 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Medical Sciences publications